for more information about stanelco click on the links.

driver's research page link
http://www.moneyam.com/InvestorsRoom/posts.php?tid=7681#lastread
website link
http://www.stanelco.co.uk/index.htm

up a bit today and don't forget they still have starpol or wrap 2000 whatever--I remember them dropping a wrapped champagne bottle out of a helicopter etc. some people are still buying!

wonder if this is to do with Biotec,
or why they are not building plants in the USA.
METABOLIX, INC.
Form:S-1/A Filing Date:11/6/2006



Our first platform, which we will be commercializing througha strategic alliance with Archer Daniels Midland Company, or ADM, is aproprietary, large-scale microbial fermentation system for producing a versatilefamily of naturally occurring polymers known as polyhydroxyalkanoates, which we call PHA Natural Plastics To exploit our first technology platform, we are working with ADM to build the Commercial Manufacturing Facility in Clinton, Iowa, which we expect will commence commercial production of PHA Natural Plastics in 2008. he facility will produce PHA Natural Plastics which are highly versatile and range in properties from strong, moldable thermoplastics to highly elastic materials and soft, sticky compositions. They can be made as resins or as latex with excellent film-forming characteristics. These properties allow for a wide variety of
commercial applications, offering an environmentally-friendly alternative to petroleum-derived synthetic materials which are not biodegradable. Through the strategic alliance with ADM we intend to initially position PHA Natural Plastics as premium priced specialty materials catering to customers who want to match the functionality of petrochemical-based plastic, but add the dimension of environmental responsibility to their products and brands.
With ADM we have initiated product and business development activities including pilot production of material at an 8 ton per month scale facility, working with potential customers, and initiation of qualification trials of our material for selected customer applications. We expect that our products will initially be sold to companies that are: establishing themselves as leaders of the emerging market trend toward environmentally responsible products and services;
Intellectual Property
Our continued success depends in large part on our proprietary technology. We rely on a combination of patent, copyright, trademark and trade secret laws, as well as confidentiality agreements, to establish and protect our proprietary rights.
We own over 320 issued patents and 100 patent applications world wide, and we have licensed from third parties approximately 60 issued patents and over 30 patent applications world wide. All but 5 of these issued patents, and their foreign counterparts, relate to the technology in our current business plan. These patents cover, among other things, the fundamental biotechnology needed to produce PHA Natural Plastics as well as compositions, processes and derived products. Of the licensed patents and patent applications, many are owned by Massachusetts Institute of Technology and exclusively licensed to us. Under the MIT licensing agreement, we currently pay annual license fees. During the fiscl year ended December 31, 2005, these fees totaled approximately $25,000. In addition, under this licensing agreement, we are obligated to pay royalties of future sales of products, if any, covered by the licensed patents.Our patents are directed to compositions of polymers, genes, vectors, expression systems in plants and bacteria, devices, coatings, films, as well as methods of manufacture and use. The terms of such patents are set to expire at various times between 2009 and 2022.
Legal Proceedings
On March 8, 2005, P&G filed a nullity action in the Federal Patent Court in Munich, Germany, against the German equivalent of one of our patents covering the method of use of producing biopolymers. The patent at issue is licensed exclusively to us by MIT and will expire in July 2010. The nullity action alleges, among other things, extension of subject matter, insufficiency of disclosure, lack of novelty, and lack of inventive step. We are controlling the response to the nullity action with MIT's cooperation. We believe this nullity action is without merit and we intend to vigorously defend this action. However, the litigation process is inherently uncertain and there can be no assurance as to the ultimate outcome of this matter. From time to time, we may be subject to other legal proceedings and claims arising in the ordinary course of business. We are not currently aware of any such proceedings or claims that we believe will have, individually or in the aggregate, a material adverse effect on our business, financial condition or results of operations.

jimward9
Don't start all the roomers again we have had enough of that over the last two years until SEO come up with a decent RNS we don't know what they are up to. As I have said before on this thread WHAT do the workers and managers do when they arrive to work each day sweet F all. .

IF this is the crux, then Given that the patent only lasts till 2010 , i think they've already lost the fight.

Up 22.9% today - you dont often see a share do that!

If I'd bought 300,000 worth yesterday I'd almost have got back what I've lost.

Damn it! Missed my chance.

Right, lets see if England can do to Brazil what SEO have been doing to us for the past three years.

The oily one

Welcome to the Stanelco Website
Please use the the menu bar to navigate through the site

This Site is currently under review. Please be patient with us while the content is updated.

Patience pays off. The market wavered a bit but finally confirmed the recent bullish formation. The dose of the previous day was not enough for a BUY-IF confirmation but today it is. The market opened with a gap up and the days activity resulted in a close higher than the open. This is a valid confirmation criterion. The market is now ready for a bullish move.

We hope that you bought this stock . You should watch the upward gap in the opening, wait a bit, feel the bullish tendency of the market making sure that prices stay over the opening price and then go long. Your benchmark was the opening
price of the upward gap.




Powered by IST's




If you bought, continue to hold this stock until the confirmation of the next SELL-IF signal. You are on safe grounds as long as the future prices continue to trade above the benchmark price.

Jimmy,

Like you want to know what the problem is re Greenseal.

Tony,

It was me re the complaint re the appropriate authority. Will E-Mail you Sat, probably PM.

Greek.

Can't help thinking back when "ii" (investorinvestor) was writing on this board a 12 month ago, that this share was going no where! He was ridiculed and squelched by some. Have learn a lesson the hard way and I'm not complaining, hope we can all salvage something out of this mess. But i think he was wiser than some on this board.

Balerboy
I recall it as "insiderinside". More than that, it was on the other side - ADVFN !
I do not think he was wiser, but almost certainly a paid deramper to support a short (EK?) - but so what?

We are where we are. What to do now?

Crikey, they say a week is a long time in politics, but its a hell of a lot longer to be away when you are invested in SEO!!!
What have you lot done???? LOL

Re the professional baiters on here. I stand by every word I wrote reference my pal at Asda. He exists, some on here know his real identity, which is very easy to verify, and I reported our conversations verbatim. All posts told you to DYOR and take it or leave it. I took him at face value, and no longer see him as he moved to another team.

Skimmed the posts as I couldn't be arsed reading them all, but has anyone asked the question re the patent challenges. If the patents are as worthless as the management and the company, why are people challenging them? They must be commercially viable, otherwise others would happily see SEO holding a worthless patent.

Anyway. Pi$$ed off to a major extent here and off to drown my sorrows.
Alan

Alan,

re: the Patents - even if they are commercially viable they could be worthless (to SEO) if they do not give SEO/Biotec exclusivity. That doesn't mean the ideas or claims of the patents are worthless. It would just mean SEO/Biotec weren't alone in being able to commercialise the ideas/claims in the patents. Hence the patents would be worthless but the ideas could be the most amazing since sliced bread and commercially very succesful!

If a comptitor/competitors can make the patents worthless (i.e. by having them revoked,invalidated, etc) the ideas in the patents would become commercially viable for them as well as SEO/Biotec!

I think what you mean is the ideas (not the patents) must be good and work otherwise no-one would be interested in challenging them. Quite right, I agree. Thats a good sign. We have to hope the ideas/claims truly belong to SEO/Biotec. We then have to hope they commercialise them and theres not much sign of that so far however brilliant the ideas may be!


BTW - I never doubted your cricket team chum (the invisible third man!) was real.

Who gives a stuff about exclusivity. SEO had an exclusivity deal with ASDA, look where that got them. Thought they had exclusivity with GS until the CC split it down the middle, and look how they've exploited that.

Even with exclusivity, they fart-arse about and others go to market with a supposedly lesser product.

gary - thats what patents are all about - exclusivity. The exclusive right to use the idea.

point taken Oblo.

hewittalan6
Al, welcome back also Pi$$ed off to a major extent, when we got to 1p I didnt think it could get any worse I still think there life in this yet but not from 6p where I am but from .006 definitely.

Just looking over the prospectus again, how many of the following have come to pass?:

10. Summary Risk Factors
An investment in Ordinary Shares involves a high degree of risk. There are risks relating to Stanelco,
to the packaging industry and to the trading market:
possible volatility of the price of the Ordinary Shares;
Stanelco may not be able to derive additional revenues from its intellectual property portfolio;
Stanelco may lose key personnel;
Stanelco may not be able to implement its strategy as described in this document;
Stanelco may be adversely affected by political, economic and regulatory factors outside of its
control;
Stanelco may not be able to successfully defend its intellectual property and risks infringing that
of other companies;
Stanelco may not receive the co-operation of SPhere in relation to the exploitation of Biotecs
intellectual property and may, as a result, need to refer the provisions of the Joint Venture
Agreement to arbitration and/or face court proceedings from SPhere and/or Biotec;
Stanelco operates in markets in which there is intense competition; and
Stanelco may have further funding requirements before becoming profitable.

Ah, it is becoming a little clearer as to why Sylvia Leavey left (no pun intended, not bad though is it?!). She must have typed the prospectus and ignored the instructions of the board to put in the words "will"/"will not"................she typed "may"/"may not" instead!

Rumor or Fact.

Just heard that the management have decided to sell the company on E Bay.
Could be a good way to go, you know how some people will pay a few quid for almost anything.
I've already put in a bid for 5. Perhaps I should have started lower.
Now I wonder how much the company would fetch.